ArticleCureus2026
Paucity of Female Sexual Dysfunction Training in Urology and Obstetrics and Gynecology Residencies.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Despite its prevalence, female sexual dysfunction (FSD) is often overlooked in medicine, particularly when compared to male sexual dysfunction (MSD). Since both urologists and obstetricians and gynecologists manage FSD, their training curricula present a unique opportunity for comparison. This study aimed to evaluate the educational landscape by assessing the availability of FSD and MSD information on American Urological Association (AUA)- and American College of Obstetrics and Gynecology (ACOG)-accredited residency program websites, recognizing that website content may not fully represent actual curricular exposure. Methods The AUA and ACOG residency program lists were used to identify Urology (n=148) and Obstetrics and Gynecology (OBGYN) (n=228) residency program websites in 2024, respectively. Data was stratified by AUA section and ACOG district where appropriate. Chi-square and Fisher's Exact Test analyses were performed to compare content. Results Review of residency websites found that content on FSD was only present on 5.3% (n=12) of OBGYN and 1.4% (n=2) of Urology program sites, while MSD content was on 50% (n=74) of Urology sites. FSD and MSD content was readily accessible with a median of one click. Among programs with this content, 83% (10/12) of OBGYN residencies detailed FSD in their curriculum, compared to 45% (33/74) of Urology programs for MSD, and none (0/2) for FSD. The presence of a faculty member specializing in FSD was a significant predictor for the inclusion of FSD content on OBGYN residency websites (OR 4.06, 95% CI 1.29-12.76; p = 0.010). In contrast, faculty subspecialty in Andrology or Sexual Medicine did not significantly predict MSD content availability on Urology sites (p > 0.05). Conclusions Female sexual dysfunction content is lacking on Urology and OBGYN residency program websites compared to MSD content. Both Urology and OBGYN specialties should make stronger efforts to incorporate FSD education in their curricula to better address women's sexual health needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.